Section background

R&D CENTER

ZK MediGroup has formed partnerships with prominent cosmeceutical manufacturers in Korea.

ZK MediGroup's partnership with reputable South Korean raw material manufacturers allows ZK MediGroup to expand its product range and gain access to high quality and innovative aesthetic products from South Korea.

ZK MediGroup|R&D CENTER ZK MediGroup|R&D CENTER ZK MediGroup|R&D CENTER ZK MediGroup|R&D CENTER ZK MediGroup|R&D CENTER

R&D Accomplishments

The creation and development of the company's aesthetic product line is based on testing and clinical trials at the R&D department. ZK MediGroup utilizes experience, research and development capabilities and provides access to a wide range of cosmeceutical products.

ZK MediGroup|R&D CENTER

HA (HYALURONIC ACID) CCT cross-linking method

Minimal modification of HA to stabilize the natural network * Minimize side effects due to minimal chemical crosslinking * Increase durability by maintaining the long chain of hyaluronic acid Stable & High elasticity despite low chemical deformation

ZK MediGroup|R&D CENTER

PCL (POLYCAPROLACTONE) + BOTALINIUM PEPTIDE

Light chain + MTD (Macro-molecule Transmission Domain) INCI Name: Methionyl r-Clostridium Botulinum Plypeptide-1 Hexapeptide-40